Research Report Identifies Avon Products, Kimberly-Clark, Boston Scientific, VF Corp, Sales Force, and Maxim Integrated Products with Renewed Outlook – Fundamental Analysis, Calculating Forward Movement

NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Avon Products, Inc. (NYSE:AVP), Kimberly-Clark Corporation (NYSE:KMB), Boston Scientific Corporation (NYSE:BSX), V.F. Corporation (NYSE:VFC), Salesforce.com, inc. (NYSE:CRM), and Maxim Integrated Products, Inc. (NASDAQ:MXIM) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AVP DOWNLOAD: http://Fundamental-Markets.com/register/?so=AVP

KMB DOWNLOAD: http://Fundamental-Markets.com/register/?so=KMB

BSX DOWNLOAD: http://Fundamental-Markets.com/register/?so=BSX

VFC DOWNLOAD: http://Fundamental-Markets.com/register/?so=VFC

CRM DOWNLOAD: http://Fundamental-Markets.com/register/?so=CRM

MXIM DOWNLOAD: http://Fundamental-Markets.com/register/?so=MXIM

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  Avon Products, Inc. (NYSE:AVP), Kimberly-Clark Corporation (NYSE:KMB), Boston Scientific Corporation (NYSE:BSX), V.F. Corporation (NYSE:VFC), Salesforce.com, inc. (NYSE:CRM), and Maxim Integrated Products, Inc. (NASDAQ:MXIM) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 7, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

AVON PRODUCTS, INC. (AVP) REPORT OVERVIEW

Avon Products' Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Avon Products reported revenue of $1,417.8 vs $1,408.8 (up 0.6%), diluted earnings per share $0.01 vs $0.07 (down 85.7%). For the twelve months ended December 31, 2016 vs December 31, 2015, Avon Products reported revenue of $5,717.7 vs $6,160.5 (down 7.2%), diluted earnings per share -$0.25 vs -$1.81.

To read the full Avon Products, Inc. (AVP) report, download it here: http://Fundamental-Markets.com/register/?so=AVP

-----------------------------------------

KIMBERLY-CLARK CORPORATION (KMB) REPORT OVERVIEW

Kimberly-Clark's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Kimberly-Clark reported revenue of $4,640 vs $4,594 (up 1.0%), diluted earnings per share $1.60 vs $1.52 (up 5.3%), and dividends per share $0.97 vs $0.92 (up 5.4%). For the twelve months ended December 31, 2016 vs December 31, 2015, Kimberly-Clark reported revenue of $18,202 vs $18,591 (down 2.1%), diluted earnings per share $5.99 vs $2.77 (up 116.2%), and dividends per share $3.64 vs $3.48 (up 4.6%).

To read the full Kimberly-Clark Corporation (KMB) report, download it here: http://Fundamental-Markets.com/register/?so=KMB

-----------------------------------------

BOSTON SCIENTIFIC CORPORATION (BSX) REPORT OVERVIEW

Boston Scientific's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Boston Scientific reported revenue of $2,222 vs $2,105 (up 5.6%), diluted earnings per share $0.20 vs $0.17 (up 17.6%). For the twelve months ended December 31, 2016 vs December 31, 2015, Boston Scientific reported revenue of $8,386 vs $7,477 (up 12.2%), diluted earnings per share $0.25 vs -$0.18.

To read the full Boston Scientific Corporation (BSX) report, download it here: http://Fundamental-Markets.com/register/?so=BSX

-----------------------------------------

V.F. CORPORATION (VFC) REPORT OVERVIEW

VF Corp's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, VF Corp reported revenue of $3,508.8 vs $3,327.7 (up 5.4%), diluted earnings per share $0.97 vs $1.19 (down 18.5%), and dividends per share $0.42 vs $0.37 (up 13.5%). For the twelve months ended December 31, 2016 vs January 2, 2016, VF Corp reported revenue of $12,019.0 vs $12,032.7 (down 0.1%), diluted earnings per share $2.78 vs $3.04 (down 8.6%), and dividends per share $1.53 vs $1.33 (up 15.0%).

To read the full V.F. Corporation (VFC) report, download it here: http://Fundamental-Markets.com/register/?so=VFC

-----------------------------------------

SALESFORCE.COM, INC. (CRM) REPORT OVERVIEW

Sales Force's Recent Financial Performance

For the three months ended July 31, 2017 vs July 31, 2016, Sales Force reported revenue of $2,561.6 vs $2,036.6 (up 25.8%), diluted earnings per share $0.02 vs $0.33 (down 93.9%). For the twelve months ended January 31, 2017 vs January 31, 2016, Sales Force reported revenue of $8,392.0 vs $6,667.2 (up 25.9%), diluted earnings per share $0.26 vs -$0.07. Sales Force is expected to report earnings on 11/21/2017. The report will be for the fiscal Quarter ending October 2017. According to Zacks Investment Research, based on 13 analysts' forecasts, the consensus EPS forecast for the quarter is $0.14. The reported EPS for the same quarter last year was $0.03.

To read the full Salesforce.com, inc. (CRM) report, download it here: http://Fundamental-Markets.com/register/?so=CRM

-----------------------------------------

MAXIM INTEGRATED PRODUCTS, INC. (MXIM) REPORT OVERVIEW

Maxim Integrated Products' Recent Financial Performance

For the three months ended September 23, 2017 vs September 24, 2016, Maxim Integrated Products reported revenue of $575.7 vs $561.4 (up 2.5%), diluted earnings per share $0.54 vs $0.48 (up 12.5%), and dividends per share $0.36 vs $0.33 (up 9.1%). For the twelve months ended June 24, 2017 vs June 25, 2016, Maxim Integrated Products reported revenue of $2,295.6 vs $2,194.7 (up 4.6%), diluted earnings per share $1.98 vs $0.79 (up 150.6%), and dividends per share $1.32 vs $1.20 (up 10.0%).

To read the full Maxim Integrated Products, Inc. (MXIM) report, download it here: http://Fundamental-Markets.com/register/?so=MXIM

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.